Building trust in locally manufactured medicines

THE global pharmaceutical landscape has shifted irrevocably; the era of strategic national self-sufficiency has begun.

We are seeing a global race for pharmaceutical sovereignty. In the United States, executive orders are streamlining permits to repatriate production. The European Union’s Critical Medicines Act is actively strengthening the availability and security of supply of essential medicines.